MedTrace Logo

Contrast-Free Magnetic Resonance Imaging for Breast Disease

NCT05006196 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1030

Last updated 2026-05-20

No results posted yet for this study

Summary

Prospective, observational cohort study looking at patients either at risk of breast cancer or have clinically suspected breast to assess the diagnostic performance of quantitative, non-contrast MRI.

Conditions

Interventions

DIAGNOSTIC_TEST

Outpatient MRI

Participation in the study includes up to a maximum of 2 study visits. The visits will include clinical measurements (height, weight, blood pressure), blood tests, MRI scan and patient symptoms and experience questionnaires. There will be no medical interventions as part of the study. All participants will receive standard-of-care by their healthcare provider/s. With the participant's consent, the participant's primary care physician will be made aware of their participation in the study. Furthermore, participants will be informed of any structural abnormalities found in the MRI scan (e.g. abnormal vessels, haemangioma, tumour, cyst, among others) and abnormal blood test results as these may have clinical implications. These will be managed by the routine clinical care team as part of standard care.

Sponsors & Collaborators

  • Perspectum

    lead INDUSTRY

Principal Investigators

  • Rajarshi Banerjee, MSc, DPhil · Honorary Consultant Physician, Oxford University NHS Foundation Trust

Eligibility

Min Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-06
Primary Completion
2026-12-31
Completion
2027-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05006196 on ClinicalTrials.gov